Bank of Montreal
VYGR icon

Bank of Montreal’s Voyager Therapeutics VYGR Stock Holding History

Bank of Montreal’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-11,499
Closed -$45.2K – 4040
2025
Q4 		$45.2K Hold
11,499
– – ﹤0.01% 3207
2025
Q3 		$53.7K Hold
11,499
– – ﹤0.01% 3105
2025
Q2 		$35.8K Buy
+11,499
New +$37.1K ﹤0.01% 3201
2021
Q2 		– Sell
-857
Closed -$4K – 4941
2021
Q1 		$4K Sell
857
-3,124
-78% -$21.3K ﹤0.01% 4765
2020
Q4 		$34K Buy
3,981
+2,667
+203% +$25.6K ﹤0.01% 4149
2020
Q3 		$14K Sell
1,314
-255,096
-99% -$2.99M ﹤0.01% 3996
2020
Q2 		$3.42M Buy
256,410
+92,645
+57% +$1.08M ﹤0.01% 1355
2020
Q1 		$1.43M Sell
163,765
-5,163
-3% -$59.3K ﹤0.01% 1576
2019
Q4 		$2.36M Buy
168,928
+165,690
+5,117% +$2.41M ﹤0.01% 1786
2019
Q3 		$56K Buy
3,238
+427
+15% +$8.96K ﹤0.01% 3559
2019
Q2 		$76K Buy
2,811
+1,994
+244% +$45.6K ﹤0.01% 3495
2019
Q1 		$15K Buy
817
+398
+95% +$5.18K ﹤0.01% 3759
2018
Q4 		$4K Sell
419
-846
-67% -$10.9K ﹤0.01% 4186
2018
Q3 		$24K Sell
1,265
-4
-0.3% -$77 ﹤0.01% 3652
2018
Q2 		$25K Sell
1,269
-448
-26% -$8.85K ﹤0.01% 3670
2018
Q1 		$32K Buy
1,717
+800
+87% +$17.3K ﹤0.01% 3409
2017
Q4 		$15K Buy
917
+800
+684% +$13.7K ﹤0.01% 3674
2017
Q3 		$2K Buy
+117
New +$1.32K ﹤0.01% 4053
2017
Q1 		– Sell
-27,293
Closed -$340K – 4208
2016
Q4 		$340K Buy
27,293
+20,575
+306% +$264K ﹤0.01% 2271
2016
Q3 		$80K Buy
6,718
+1,658
+33% +$22.4K ﹤0.01% 2889
2016
Q2 		$56K Buy
+5,060
New +$61.9K ﹤0.01% 3025

Other funds holding VYGR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bank of Montreal's VYGR Position: Q1 2026 in Review

Bank of Montreal sold out of Voyager Therapeutics (VYGR) in Q1 2026, closing a stake of 11,499 shares — an estimated $45.2K sold.

Bank of Montreal first reported a position in VYGR in Q2 2016 and held it in 21 quarters. The position peaked at $3.42M in Q2 2020. 135 funds tracked by Wall St. Rank hold VYGR as of Q1 2026.

  • Bank of Montreal reported no remaining Voyager Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Bank of Montreal sold 11,499 Voyager Therapeutics shares in Q1 2026, an estimated $45.2K.
  • Bank of Montreal first reported a position in Voyager Therapeutics in Q2 2016 and held it in 21 quarters.
  • Bank of Montreal's Voyager Therapeutics position peaked at $3.42M in Q2 2020.
  • 135 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q1 2026.

Based on Bank of Montreal's 13F filing for Q1 2026, filed 13 May 2026.